Annual zoledronic acid infusion lowers risk of fracture, death.
Year: 2007
Type: article
Abstract: Patients with a prior hip fracture have 2.5 times the risk of a new fracture compared to age-matched persons without a previous hip fracture. For patients with a recent hip fracture, intravenous zoledronic acid annually is an option for reducing the risk of new fractures and death. Stength of recommendation (SOR) B: based on one well- designed randomized controlled trial.
Source: Europe PMC (PubMed Central)
Authors: Sarah-Anne Schumann, John Hickner
Institution: University of Chicago
Language: English
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2413204478